Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program.

Int J Gynecol Cancer · 2023 · PMC9811074 · PMID 36600534

Europe PMC DOI

hedged sentence

0.2500

closest p · 5.0× alpha

0.2500

boldest claim

The sentences

did not reach statistical significancep=0.25not close (p > 0.1)

5 This apparent improvement in RFS did not reach statistical significance (HR 0.68, 95% CI 0.36 to 1.30, p=0.25).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.